Skip to main content

Table 4 Associations of female reproductive tract infections and estrogen exposure with breast cancer prognosis

From: Interaction of reproductive tract infections with estrogen exposure on breast cancer risk and prognosis

Variables

Total

OS

PFS

Events (%)

HR (95%CI)a

HR (95%CI)b

Events (%)

HR (95%CI)a

HR (95%CI)b

Reproductive tract infections

 No

3579

262 (7.3)

1.00 (reference)

1.00 (reference)

494 (13.8)

1.00 (reference)

1.00 (reference)

 Yes

685

37 (5.4)

0.59 (0.42,0.83)

0.61 (0.40,0.94)

104 (15.1)

0.85 (0.68,1.05)

0.84 (0.65,1.09)

Number of menstrual cycles

  ≤ 327

1105

86 (7.8)

1.00 (reference)

1.00 (reference)

177 (16.0)

1.00 (reference)

1.00 (reference)

  > 327

2208

164 (7.4)

0.96 (0.74,1.24)

0.82 (0.57, 1,18)

304 (13.8)

0.87 (0.72,1.05)

0.92 (0.70,1.21)

Reproductive time—Duration of parity—Breastfeeding duration (years)

  ≤ 25

1147

88 (7.7)

1.00 (reference)

1.00 (reference)

184 (16.0)

1.00 (reference)

1.00 (reference)

  > 25

2307

170 (7.4)

0.98 (0.76,1.27)

0.78 (0.51,1.17)

318 (13.8)

0.88 (0.74,1.06)

1.02 (0.73,1.42)

Reproductive time—Duration of all pregnancies—Breastfeeding duration (years)

  ≤ 25

1100

88 (8.0)

1.00 (reference)

1.00 (reference)

179 (16.3)

1.00 (reference)

1.00 (reference)

  > 25

2195

163 (7.4)

0.94 (0.73,1.23)

0.70 (0.47,1.06)

309 (14.1)

0.89 (0.74,1.07)

1.01 (0.72,1.41)

  1. a The univariate COX model
  2. b The multivariate COX model, adjusted for age at diagnosis, menopausal, education, marital status, BMI, ER status, HER2 status, family history, clinical stage